Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma Pubmed



Khorasanizadeh M1 ; Eskian M1 ; Rezaei N1, 2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Acta Medica Iranica Published:2017


Abstract

[No abstract available]
Related Docs
1. Efficacy and Safety of Benralizumab, a Monoclonal Antibody Against Il-5Rα, in Uncontrolled Eosinophilic Asthma, International Reviews of Immunology (2016)
2. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis, Clinical Reviews in Allergy and Immunology (2018)
Experts (# of related papers)
Nima Rezaei (2)